WallStSmart
ZLAB

Zai Lab Ltd

NASDAQ: ZLAB · HEALTHCARE · BIOTECHNOLOGY

$20.75
-6.28% today

Updated 2026-04-29

Market cap
$2.33B
P/E ratio
P/S ratio
5.07x
EPS (TTM)
$-1.60
Dividend yield
52W range
$16 – $44
Volume
0.8M

Zai Lab Ltd (ZLAB) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20152016201720182019202020212022202320242025
Revenue$0.00$0.00$0.00$129452.00$12.98M$48.96M$144.31M$215.04M$266.72M$398.99M$460.16M
Revenue growth (YoY)+9930.6%+277.0%+194.8%+49.0%+24.0%+49.6%+15.3%
Cost of revenue$0.00$0.00$0.00$43590.00$3.75M$239.45M$52.24M$74.02M$95.82M$147.86M$190.52M
Gross profit$0.00$0.00$0.00$85862.00$9.24M$-190.49M$92.07M$141.02M$170.90M$251.13M$269.64M
Gross margin66.3%71.1%-389.1%63.8%65.6%64.1%62.9%58.6%
R&D$13.59M$32.15M$39.34M$120.28M$142.22M$222.71M$573.31M$286.41M$265.87M$234.50M$220.90M
SG&A$2.76M$6.38M$12.05M$21.58M$70.21M$111.31M$218.83M$197.46M$281.61M$298.74M$277.61M
Operating income$-16.35M$-38.53M$-51.39M$-141.77M$-203.20M$-301.80M$-700.06M$-404.36M$-366.57M$-282.12M$-229.43M
Operating margin-109514.0%-1564.9%-616.4%-485.1%-188.0%-137.4%-70.7%-49.9%
EBITDA$-16.22M$-38.33M$-50.84M$-138.45M$-199.43M$-297.16M$-689.46M$-434.84M$-365.11M$-234.57M$-158.25M
EBITDA margin-106949.8%-1535.9%-607.0%-477.8%-202.2%-136.9%-58.8%-34.4%
EBIT$-16.35M$-38.53M$-51.39M$-140.10M$-203.20M$-301.80M$-695.95M$-443.06M$-374.14M$-254.85M$-173.25M
Interest expense$1.67M$1.02M$1.26M$39672.00$293000.00$181000.00$3.35M$14.58M$14.58M$2.25M$5.21M
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-18.02M$-37.51M$-50.38M$-139.07M$-183.37M$-268.90M$-704.47M$-443.29M$-334.62M$-257.10M$-175.54M
Net income growth (YoY)-108.1%-34.3%-176.0%-31.8%-46.6%-162.0%+37.1%+24.5%+23.2%+31.7%
Profit margin-107433.6%-1412.2%-549.3%-488.2%-206.1%-125.5%-64.4%-38.1%